Search for: "ACTAVIS" Results 621 - 640 of 1,006
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Dec 2013, 1:23 pm
Similarly in Actavis v Eli Lilly [2013] EWCA Civ 517, the Court of Appeal confirmed that the English courts have jurisdiction to hear claims for declarations of non-infringement in relation to foreign designations of European patents where there is no challenge to validity. [read post]
12 Dec 2013, 7:12 am
 In the meantime, here they are in outline:Case C‑443/12, Actavis Group PTC EHF, Actavis UK Ltd v Sanofi, Sanofi Pharma Bristol-Myers Squibb SNC intervening, noted on The SPC Blog here. [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
18 Nov 2013, 11:40 am by Gene Quinn
Actavis PLC (NYSE: ACT) recently filed an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
17 Nov 2013, 8:56 pm by Patent Docs
• Defendants: Watson Laboratories Inc; Actavis, Inc.; Actavis Pharma, Inc. [read post]
6 Nov 2013, 9:35 pm by Patent Docs
This referral follows three earlier referrals to the CJEU concerning the interpretation of the SPC Regulation in the cases of Actavis v Sanofi, Lilly v Human Genome Sciences and Georgetown University. [read post]
4 Nov 2013, 9:55 pm by Patent Docs
Actavis sought a cross-undertaking that allowed (i) any company in the Actavis group and (ii) any customer or potential customer... [read post]
4 Nov 2013, 12:00 am by D Daniel Sokol
Butler, George Mason University School of Law discuss Activating Actavis: Economic Issues in Applying the Rule of Reason to Reverse Payment Settlements. [read post]
28 Oct 2013, 12:43 pm by Gene Quinn
Mouse Model of Parkinson's Disease Shows Improved Brain Function --- DARPA Awards $25 Million To Develop Messenger RNA Therapeutics™ --- Actavis Files ANDA for Generic Suboxone® Sublingual Film --- AzaSite® Patents Upheld in Patent Infringement Lawsuit Against Sandoz --- Surgeons Successfully Remove "Inoperable" Metastatic Breast Cancer --- Actavis Files ANDA on Acanya® Gel, Gets Sued by Dow, Valeant --- NYSE Inquires About Unusual Market Activity for Ampio… [read post]
28 Oct 2013, 12:43 pm by Gene Quinn
Linda Venczel as New Program Director --- Actavis's settles with FTC over $8.5 Billion acquisition of Warner Chilcott [read post]
20 Oct 2013, 8:00 pm by Patent Docs
October 22, 2013 - Patent 'Trolls' Under Fire: Strategies, Tactics and Legislation Impacting University Patents & Licensing (Technology Transfer Tactics) - 1:00 to 2:00 pm (Eastern) October 22, 2013 - Reverse-Payment License Agreements: A Review of the Hatch-Waxman Act Post-Actavis (American Bar Association Section of Intellectual Property Law, Young Lawyers Division, and Center for Professional Development) - 2:00 to 3:30 pm (Eastern) October 23, 2013 - European biotech patent law… [read post]
17 Oct 2013, 12:42 pm
 He therefore permitted Actavis's wording in respect of the Actavis group. [read post]
17 Oct 2013, 12:19 pm
This question related to whether the combination product is protected by the amended patent and stems from the idea advanced by Actavis and by Arnold J in Actavis v Sanofi that the combination product may need to embody a separate inventive advance. [read post]
17 Oct 2013, 11:09 am by Glenn
Xerox relied on the same scope of the patent standard rejected in Actavis to immunize a patent holder’s unilateral refusal to license; that holding is open to question today. [read post]
17 Oct 2013, 5:00 am by Kimberly A. Kralowec
Our panelists include the attorney who argued Actavis in the Supreme Court, the leading academician on the subject, trial counsel in Cipro and other class action challenges to reverse settlements, and is moderated by the attorney who filed the Actavis Case. [read post]
13 Oct 2013, 8:36 pm by Patent Docs
October 15-17, 2013 - Business of Biosimilars*** (Institute for International Research) - Boston, MA October 16, 2013 - Post-Grant Review -- Coming Soon (Intellectual Property Owners Association) - 2:00 to 3:00 pm (ET) October 22, 2013 - Patent 'Trolls' Under Fire: Strategies, Tactics and Legislation Impacting University Patents & Licensing (Technology Transfer Tactics) - 1:00 to 2:00 pm (Eastern) October 22, 2013 - Reverse-Payment License Agreements: A Review of the Hatch-Waxman Act… [read post]